|
Arthur M. Friedlander, M.D
Senior Scientist/Science Advisor USAMRIID
1425 Porter Street Frederick, MD 21702 Tel: 301.619.7343 FAX: 301.619.4299 email: arthur.friedlander@amedd.army.mil
ARTHUR M. FRIEDLANDER, M.D.
is currently the Senior Scientist at
the U.S. Army Medical Research
Institute of Infectious Diseases (USAMRIID).
He
received his medical degree from the University of
Pittsburgh after graduating from Harvard College.
After completing medical training and a postdoctoral
fellowship at the National Cancer Institute, Dr. Friedlander was an NIH
Postdoctoral Research Fellow in Infectious
Diseases at the University of California School of Medicine in San Diego, CA
where he subsequently became Assistant Professor.
He then joined USAMRIID as a Principal Research
Investigator, and in the following years was Chief of Airborne Diseases
Division; Chief of the Department of Pathobiology, Pathology Division; and Chief
of the Bacteriology Division.
He is currently Adjunct Professor of Medicine,
Uniformed Services University of the Health Sciences School of Medicine.
Dr. Friedlander's research interests are in the
pathogenesis of infectious diseases and in vaccine development.
His research has led to the identification of the
macrophage as the target cell for the anthrax lethal toxin and to our current
understanding of how the toxins interact with eucaryotic cells.
He directed the studies that demonstrated the value
of postexposure antibiotic prophylaxis for anthrax, which provided the evidence
for the current recommendations for treatment in humans.
He also directed the research programs that resulted
in new generation vaccine candidates for both anthrax and plague that are
currently in human clinical trials and has patents filed for both.
He is a Fellow of the
Infectious Diseases Society of America and a
recipient of the Army Research and Development Achievement Award and the Jay P.
Sanford Award in Infectious Diseases.
Dr. Friedlander is also the most highly cited author
in Bioterrorism Research in the period 1999-2008.
|
